| Inflammation and immunity in IPF pathogenesis and treatment |
25 |
| Airway clearance techniques in neuromuscular disorders: A state of the art review |
23 |
| Emerging concerns of infectious diseases in lung cancer patients receiving immune checkpoint inhibitor therapy |
19 |
| Blood eosinophil levels as a biomarker in COPD |
16 |
| VEGF and FGF-2: Promising targets for the treatment of respiratory disorders |
16 |
| Misdiagnosis of asthma and COPD and underuse of spirometry in primary care unselected patients |
16 |
| Prevalence and risk factors of asthma in mainland China: The CARE study |
16 |
| Effect of a mHealth intervention on adherence in adolescents with asthma: A randomized controlled trial |
14 |
| Clinical, serological and radiological features of a prospective cohort of Interstitial Pneumonia with Autoimmune Features (IPAF) patients |
14 |
| Rate of, and barriers and enablers to, pulmonary rehabilitation referral in COPD: A systematic scoping review |
13 |
| Malnutrition and sarcopenia assessment in patients with chronic obstructive pulmonary disease according to international diagnostic criteria, and evaluation of raw BIA variables |
13 |
| No evidence found for an association between prednisone dose and FVC change in newly-treated pulmonary sarcoidosis |
12 |
| Burden of pneumococcal community-acquired pneumonia in adults across Europe: A literature review |
12 |
| Pirfenidone in patients with idiopathic pulmonary fibrosis and more advanced lung function impairment |
12 |
| Scottish consensus statement on the role of FeNO in adult asthma |
11 |
| Revefenacin, a once-daily, lung-selective, long-acting muscarinic antagonist for nebulized therapy: Safety and tolerability results of a 52-week phase 3 trial in moderate to very severe chronic obstructive pulmonary disease |
11 |
| Efficacy and safety of infliximab biosimilar Inflectra (R) in severe sarcoidosis |
11 |
| Clinical features of sarcoidosis associated pulmonary hypertension: Results of a multi-national registry |
11 |
| The short-term effects of air pollution on respiratory diseases and lung cancer mortality in Hefei: A time-series analysis |
10 |
| Lung function outcomes in the INPULSIS (R) trials of nintedanib in idiopathic pulmonary fibrosis |
10 |
| What can we learn about COPD from impulse oscillometry? |
10 |
| Real-world safety and efficacy of omalizumab in patients with severe allergic asthma: A long-term post-marketing study in Japan |
10 |
| Salvage therapies for refractory hypoxemia in ARDS |
10 |
| Association between vitamin D status and asthma control: A meta-analysis of randomized trials |
10 |
| Disconnect of type 2 biomarkers in severe asthma; dominated by FeNO as a predictor of exacerbations and periostin as predictor of reduced lung function |
10 |
| The role of evaluating inspiratory constraints and ventilatory inefficiency in the investigation of dyspnea of unclear etiology |
9 |
| Omalizumab as alternative to chronic use of oral corticosteroids in severe asthma |
9 |
| Clinical approach and review of causes of a chylothorax |
9 |
| Lymphocytic focus score is positively related to airway and interstitial lung diseases in primary Sjogren's syndrome |
9 |
| Serum CXCL11 correlates with pulmonary outcomes and disease burden in sarcoidosis |
9 |
| Selective upper airway stimulation in older patients |
9 |
| Pediatric rhinosinusitis and asthma |
9 |
| The revised GOLD 2017 COPD categorization in relation to comorbidities |
9 |
| Clinical and economic burden of severe asthma: A French cohort study |
9 |
| Early life determinants of lung function change from childhood to adolescence |
9 |
| Asthma and its comorbidities in middle-aged and older adults; the Rotterdam Study |
8 |
| Impact of eHealth on medication adherence among patients with asthma: A systematic review and meta-analysis |
8 |
| Functional associations of pleuroparenchymal fibroelastosis and emphysema with hypersensitivity pneumonitis |
8 |
| The role of high resolution oesophageal manometry in occult respiratory symptoms |
8 |
| Tiotropium add-on to inhaled corticosteroids versus addition of long-acting beta(2)-agonists for adults with asthma |
8 |
| Mepolizumab improves small airway function in severe eosinophilic asthma |
8 |
| Prevalence and trend of COPD from 1995-1997 to 2006-2008: The HUNT study, Norway |
8 |
| Airway wall thickening on CT: Relation to smoking status and severity of COPD |
8 |
| Combined pulmonary fibrosis and emphysema as a clinicoradiologic entity: Characterization of presenting lung fibrosis and implications for survival |
8 |
| Several high-resolution computed tomography findings associate with survival and clinical features in rheumatoid arthritis-associated interstitial lung disease |
8 |
| The spectrum of pulmonary aspergillosis |
8 |
| Pleuroparenchymal fibroelastosis diagnosed by multidisciplinary discussions in Japan |
8 |
| Evaluation of criteria for clinical control in a prospective, international, multicenter study of patients with COPD |
8 |
| A phase III study of triple therapy with budesonide/glycopyrrolate/ formoterol fumarate metered dose inhaler 320/18/9.6 mu g and 160/18/9.6 mu g using co-suspension delivery technology in moderate-to-very severe COPD: The ETHOS study protocol |
8 |
| Persistent air leak - review |
8 |
